February 22, 2023 Comments Off on New patent for Novartis drug TAFINLAR Posted in: Patent Added Annual Drug Patent Expirations for TAFINLAR Tafinlar is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are seven patents protecting…
The post New patent for Novartis drug TAFINLAR appeared first on Drug…
February 17, 2023 Comments Off on New patent for Teva Branded drug AUSTEDO Posted in: Patent Added Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from one supplier. There are nine…
The post New patent for Teva Branded drug AUSTEDO appeared first on DrugPatentWat…